By Counterforce Health Team in Dupixent (dupilumab) —

How to Get Dupixent (Dupilumab) Covered by Aetna CVS Health in New Jersey: Complete Guide to Prior Authorization, Appeals, and Approval

Answer Box: Getting Dupixent Covered by Aetna CVS Health in New Jersey

Dupixent (dupilumab) is covered by Aetna CVS Health for FDA-approved conditions but requires prior authorization. Success depends on documenting failed conventional therapies and meeting specific clinical criteria. Your fastest path: 1) Have your specialist submit a complete PA request with treatment history, 2) Use CVS Specialty Pharmacy for enrollment, 3) If denied, appeal within 180 days with detailed medical necessity documentation. Start today: Contact your dermatologist or pulmonologist to initiate the prior authorization process through Aetna's provider portal.

Table of Contents

Plan Types and Network Requirements

HMO, PPO, and EPO Differences

For Aetna plans in New Jersey, no referrals are required to see dermatologists or pulmonologists under most Open Access HMO, PPO, or EPO plans. You can self-refer to in-network specialists, but you must stay within Aetna's provider network for coverage.

Key requirements:

  • Use only in-network providers (especially critical for HMO and EPO plans)
  • Specialist copays typically apply ($10-50+ depending on your plan)
  • All care must be medically necessary
  • Out-of-network care generally not covered except for emergencies
Tip: Use Aetna's "Find a Doctor" tool to locate network dermatologists and pulmonologists in New Jersey before scheduling appointments.

Formulary Status and Tier Placement

Dupixent is classified as a specialty medication on Aetna formularies, typically placed on Tier 2 or higher specialty tiers. This placement results in higher out-of-pocket costs compared to generic medications.

Coverage at a Glance

Requirement Details Where to Find It
Prior Authorization Required for all indications Aetna Precertification Lists
Formulary Tier Tier 2+ (specialty) Your plan's drug formulary
Step Therapy Often required Aetna clinical policy bulletins
Quantity Limits Standard FDA dosing Aetna Specialty Quantity Limits
Age Restrictions Varies by indication FDA labeling requirements

Covered indications include:

  • Moderate-to-severe atopic dermatitis (≥6 months)
  • Asthma add-on therapy (≥6 years)
  • Chronic rhinosinusitis with nasal polyps
  • Prurigo nodularis
  • Eosinophilic esophagitis
  • COPD add-on therapy (adults)

Prior Authorization Requirements

Clinical Documentation Needed

For Atopic Dermatitis:

  • EASI (Eczema Area and Severity Index) or IGA (Investigator's Global Assessment) scores showing moderate-to-severe disease
  • Documentation of failed topical therapies (corticosteroids, calcineurin inhibitors)
  • Evidence of quality of life impact
  • Dermatologist evaluation and ongoing care

For Asthma:

  • Spirometry results demonstrating impaired function
  • Asthma Control Test (ACT) or Asthma Control Questionnaire (ACQ) scores
  • History of exacerbations requiring systemic steroids or hospitalization
  • Evidence of eosinophilic or Th2-high phenotype (if required)
  • Failed trials of inhaled corticosteroids and long-acting beta-agonists

Universal Requirements:

  • Correct ICD-10 diagnosis codes
  • Prescriber NPI and specialty credentials
  • Treatment plan with monitoring schedule
  • Documentation that alternatives are inappropriate
Note: Aetna requires that prescribing be done or overseen by relevant specialists (dermatology, allergy/immunology, pulmonology) for optimal approval chances.

Specialty Pharmacy Setup

Aetna partners with CVS Specialty Pharmacy for Dupixent distribution. The enrollment process requires coordination between your provider, CVS Specialty, and the Dupixent MyWay support program.

Enrollment Steps

  1. Complete enrollment forms with both patient and provider signatures
  2. Submit to CVS Specialty via their referral fax line
  3. Benefits investigation conducted by CVS Specialty or Dupixent MyWay
  4. Prior authorization submitted by the specialty pharmacy
  5. Patient contact for delivery scheduling and copay assistance

Required information:

  • Complete patient demographics and insurance details
  • Prescriber NPI and practice information
  • Diagnosis with ICD-10 code (one primary diagnosis)
  • Preferred contact method for the patient
  • Last four digits of patient's SSN

For enrollment assistance, contact Dupixent MyWay Support at 1-844-387-4936 (Monday-Friday, 8 AM to 9 PM ET).

Step-by-Step: Fastest Path to Approval

  1. Schedule specialist consultation - See an in-network dermatologist, pulmonologist, or allergist
  2. Document treatment history - Compile records of all prior therapies, outcomes, and side effects
  3. Complete diagnostic assessments - Obtain severity scores (EASI, IGA, ACT, spirometry as appropriate)
  4. Submit comprehensive PA request - Provider submits via Aetna portal with all required documentation
  5. Enroll with specialty pharmacy - Complete CVS Specialty and Dupixent MyWay enrollment forms
  6. Follow up on decision - Aetna typically responds within 30-45 days for standard requests
  7. Appeal if denied - Submit appeal within 180 days with additional medical justification

Timeline expectations:

  • Specialist appointment: 1-4 weeks
  • PA decision: 30-45 days (72 hours for expedited)
  • Appeal decision: 30-60 days internal, 45 days external

Common Denial Reasons and Solutions

Denial Reason Solution
Insufficient severity documentation Submit EASI/IGA scores, clinical photos, quality of life assessments
Lack of step therapy compliance Document specific failures, intolerances, or contraindications to required therapies
Missing specialist involvement Ensure prescription comes from appropriate specialist (dermatology, pulmonology, allergy)
Inadequate treatment history Provide detailed records of all prior therapies with dates, durations, and outcomes
Non-formulary status Request formulary exception with medical necessity justification
Age restrictions Verify FDA-approved age ranges for specific indication

Success factors: Appeals are successful over 80% of the time when proper documentation addressing the specific denial reason is provided.

Appeals Process in New Jersey

Internal Appeals with Aetna

First Level Appeal:

  • Deadline: 180 days from denial date
  • Timeline: 30 days for standard, 72 hours for expedited
  • How to file: Aetna member portal, phone (1-800-537-9384), or written request
  • Required: Copy of denial letter, additional medical documentation, provider statement

Second Level Appeal:

  • Automatic: If first appeal is denied
  • Timeline: 30 days for decision
  • Review: Independent medical professionals

External Review in New Jersey

After completing Aetna's internal appeals, New Jersey residents can access the Independent Health Care Appeals Program (IHCAP) through Maximus Federal Services.

Key details:

  • Deadline: 180 days from final internal denial
  • Cost: Free to patients
  • Timeline: 5 business days for acceptance review, 45 days for final decision
  • Expedited: Available for urgent cases
  • Decision: Binding on Aetna if overturned

Contact for external appeals:

  • IHCAP Hotline: 1-888-393-1062
  • NJ DOBI Consumer Hotline: 1-800-446-7467
From our advocates: We've seen cases where patients initially denied for Dupixent were approved after providing detailed documentation of topical therapy failures and quality of life impact scores. The key was having the dermatologist write a comprehensive letter addressing each specific denial reason with supporting clinical evidence.

Costs and Patient Assistance

List price: Approximately $3,993 per carton (two injections) as of January 2025, though most patients don't pay list price.

Financial Assistance Options

Dupixent MyWay Copay Card:

  • Eligible commercially insured patients may pay as little as $10 per prescription
  • Not valid for government insurance (Medicare, Medicaid)
  • Dupixent Savings Program

Patient Assistance Programs:

  • Income-based free drug programs for uninsured/underinsured patients
  • Foundation grants through organizations like HealthWell Foundation
  • State pharmaceutical assistance programs in New Jersey

Insurance considerations:

  • Specialty tier copays typically range from $50-500+ per month
  • Annual out-of-pocket maximums provide cost protection
  • Some plans require meeting deductible before copay assistance applies

FAQ

Q: How long does Aetna prior authorization take in New Jersey? A: Standard requests typically take 30-45 days. Expedited requests (for urgent medical needs) are decided within 72 hours.

Q: What if Dupixent is not on my Aetna formulary? A: You can request a formulary exception. Your doctor must provide documentation that covered alternatives are not appropriate or effective for your condition.

Q: Can I appeal if I've tried step therapy medications outside New Jersey? A: Yes, document all prior therapies regardless of where they were tried. Include medical records showing specific medications, durations, and reasons for discontinuation.

Q: Does Aetna require specific specialists to prescribe Dupixent? A: While not always mandatory, having a dermatologist (for skin conditions) or pulmonologist/allergist (for respiratory conditions) prescribe significantly improves approval odds.

Q: What happens if my appeal is denied by Aetna? A: New Jersey residents can file for external review through IHCAP at no cost. This provides an independent medical review with binding decisions.

Q: How do I get expedited review for urgent cases? A: Contact Aetna directly and request expedited prior authorization or appeal. You'll need documentation showing that delays would cause serious harm to your health.

Q: Can my doctor request a peer-to-peer review? A: Yes, your prescribing physician can request to speak directly with Aetna's medical director to discuss your case and provide additional clinical context.

Q: What if I'm switching from another insurance plan where Dupixent was covered? A: Aetna still requires their own prior authorization process, but previous treatment success and current clinical stability can strengthen your case.

Counterforce Health helps patients, clinicians, and specialty pharmacies turn insurance denials into targeted, evidence-backed appeals. Our platform analyzes denial letters and plan policies to draft point-by-point rebuttals aligned with each payer's specific requirements. By combining the right clinical evidence with procedural expertise, we help improve approval rates while reducing administrative burden on healthcare providers.

For additional support with complex insurance coverage challenges, consider working with advocacy services like Counterforce Health that specialize in prior authorization appeals and can help ensure your documentation meets Aetna's specific requirements.

Sources & Further Reading

Disclaimer: This information is for educational purposes only and does not constitute medical or legal advice. Coverage policies vary by plan and state. Always verify current requirements with your insurance provider and consult your healthcare provider for medical decisions. For personalized assistance with appeals or coverage questions, contact your state insurance department or consider working with a patient advocacy service.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.